IBDEI089 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3724,1,5,0)
 ;;=5^SCC of skin of arm/shoulder
 ;;^UTILITY(U,$J,358.3,3724,2)
 ;;=^340483
 ;;^UTILITY(U,$J,358.3,3725,0)
 ;;=173.69^^31^333^28
 ;;^UTILITY(U,$J,358.3,3725,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3725,1,2,0)
 ;;=2^173.69
 ;;^UTILITY(U,$J,358.3,3725,1,5,0)
 ;;=5^Other spec neoplasm skin, arm/shoulder
 ;;^UTILITY(U,$J,358.3,3725,2)
 ;;=^340484
 ;;^UTILITY(U,$J,358.3,3726,0)
 ;;=173.70^^31^333^29
 ;;^UTILITY(U,$J,358.3,3726,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3726,1,2,0)
 ;;=2^173.70
 ;;^UTILITY(U,$J,358.3,3726,1,5,0)
 ;;=5^Malig neoplasm skin, leg/hip
 ;;^UTILITY(U,$J,358.3,3726,2)
 ;;=^340603
 ;;^UTILITY(U,$J,358.3,3727,0)
 ;;=173.71^^31^333^30
 ;;^UTILITY(U,$J,358.3,3727,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3727,1,2,0)
 ;;=2^173.71
 ;;^UTILITY(U,$J,358.3,3727,1,5,0)
 ;;=5^BCC of skin of leg/hip
 ;;^UTILITY(U,$J,358.3,3727,2)
 ;;=^340485
 ;;^UTILITY(U,$J,358.3,3728,0)
 ;;=173.72^^31^333^31
 ;;^UTILITY(U,$J,358.3,3728,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3728,1,2,0)
 ;;=2^173.72
 ;;^UTILITY(U,$J,358.3,3728,1,5,0)
 ;;=5^SCC of skin of leg/hip
 ;;^UTILITY(U,$J,358.3,3728,2)
 ;;=^340486
 ;;^UTILITY(U,$J,358.3,3729,0)
 ;;=173.79^^31^333^32
 ;;^UTILITY(U,$J,358.3,3729,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3729,1,2,0)
 ;;=2^173.79
 ;;^UTILITY(U,$J,358.3,3729,1,5,0)
 ;;=5^Other spec neoplasm skin, leg/hip
 ;;^UTILITY(U,$J,358.3,3729,2)
 ;;=^340487
 ;;^UTILITY(U,$J,358.3,3730,0)
 ;;=173.80^^31^333^33
 ;;^UTILITY(U,$J,358.3,3730,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3730,1,2,0)
 ;;=2^173.80
 ;;^UTILITY(U,$J,358.3,3730,1,5,0)
 ;;=5^Malig neoplasm skin, other sites NOS
 ;;^UTILITY(U,$J,358.3,3730,2)
 ;;=^340604
 ;;^UTILITY(U,$J,358.3,3731,0)
 ;;=173.81^^31^333^34
 ;;^UTILITY(U,$J,358.3,3731,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3731,1,2,0)
 ;;=2^173.81
 ;;^UTILITY(U,$J,358.3,3731,1,5,0)
 ;;=5^BCC of skin of specified sites
 ;;^UTILITY(U,$J,358.3,3731,2)
 ;;=^340488
 ;;^UTILITY(U,$J,358.3,3732,0)
 ;;=173.82^^31^333^35
 ;;^UTILITY(U,$J,358.3,3732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3732,1,2,0)
 ;;=2^173.82
 ;;^UTILITY(U,$J,358.3,3732,1,5,0)
 ;;=5^SCC of skin of specified sites
 ;;^UTILITY(U,$J,358.3,3732,2)
 ;;=^340489
 ;;^UTILITY(U,$J,358.3,3733,0)
 ;;=173.89^^31^333^36
 ;;^UTILITY(U,$J,358.3,3733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3733,1,2,0)
 ;;=2^173.89
 ;;^UTILITY(U,$J,358.3,3733,1,5,0)
 ;;=5^Other spec neoplasm skin, other sites
 ;;^UTILITY(U,$J,358.3,3733,2)
 ;;=^340490
 ;;^UTILITY(U,$J,358.3,3734,0)
 ;;=173.90^^31^333^37
 ;;^UTILITY(U,$J,358.3,3734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3734,1,2,0)
 ;;=2^173.90
 ;;^UTILITY(U,$J,358.3,3734,1,5,0)
 ;;=5^Malig neoplasm skin, site unspec
 ;;^UTILITY(U,$J,358.3,3734,2)
 ;;=^340605
 ;;^UTILITY(U,$J,358.3,3735,0)
 ;;=173.91^^31^333^38
 ;;^UTILITY(U,$J,358.3,3735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3735,1,2,0)
 ;;=2^173.91
 ;;^UTILITY(U,$J,358.3,3735,1,5,0)
 ;;=5^BCC of skin, unspecified site
 ;;^UTILITY(U,$J,358.3,3735,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,3736,0)
 ;;=173.92^^31^333^39
 ;;^UTILITY(U,$J,358.3,3736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3736,1,2,0)
 ;;=2^173.92
 ;;^UTILITY(U,$J,358.3,3736,1,5,0)
 ;;=5^SCC of skin, unspecified site
 ;;^UTILITY(U,$J,358.3,3736,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,3737,0)
 ;;=173.99^^31^333^40
 ;;^UTILITY(U,$J,358.3,3737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3737,1,2,0)
 ;;=2^173.99
 ;;^UTILITY(U,$J,358.3,3737,1,5,0)
 ;;=5^Other spec neoplasm skin, site unspec
 ;;^UTILITY(U,$J,358.3,3737,2)
 ;;=^340493
